Home / States / Georgia

Georgia: compound legality at a glance

In Georgia, Compound Laws tracks 19 compounds: 3 legal to sell at retail, 6 restricted, 0 in a gray area, 4 illegal, 1 not yet verified, and 5 whose status varies by product form. Verified through October 22, 2026.

Legal 3 · Restricted 6 · Gray 0 · Illegal 4 · Not verified 1

Every tracked compound in Georgia

Recent status changes in Georgia

Pending deadlines

  • 2026-12-31 · GA · 7-OH (7-Hydroxymitragynine): GA HB 968 - would reclassify mitragynine/7-OH to Schedule I (2026; pending, House Second Readers) (HB 968)

Verbatim law on file for Georgia

Ga. Comp. R. & Regs. r. 40-32-5-.01(1)(a) and r. 40-32-5-.06 · Standards for Consumable Hemp Products; Serving Sizes and Serving LimitsOFFICIAL
Instrument
Standards for Consumable Hemp Products; Serving Sizes and Serving Limits
Source
https://rules.sos.ga.gov/gac/40-32-5
Retrieved
2026-07-18
Fingerprint
3a4492bd3c58ed4e
40-32-5-.01(1) General Standards. All consumable hemp products in the state of Georgia must conform with the standards established in the Georgia Hemp Farming Act and this Chapter. (a) Prohibited Forms of Consumable Hemp Products. The following products shall not be sold, offered for sale, or otherwise distributed as consumable hemp products in Georgia: 1. The flower or leaves of the Cannabis sativa L. plant, regardless of the total delta-9-THC concentration in such flower or leaves; 2. Products that contain alcohol or constitute an alcoholic beverage under Title 3 of the Official Code of Georgia Annotated; 3. Marijuana products or low THC oil products; 4. Food products, including, but not limited to, dairy, meat, and seafood products; and 5. Any hemp product containing a non-cannabinoid additive that would increase potency, toxicity, or addictive potential, or that would create an unsafe combination with other psychoactive substances including, but not limited to, nicotine. 40-32-5-.06(1) Maximum Serving Sizes and Serving Limits. Consumable hemp products in final packaged form shall not contain an amount of total delta-9-THC in excess of the limits prescribed herein. (a) A consumable hemp product in the form of a gummy shall not contain more than: 1. 10 milligrams of total delta-9-THC per gummy; and 2. 300 milligrams of total delta-9-THC per package. (b) A consumable hemp product in the form of a beverage shall: 1. Not contain more than 10 milligrams of total delta-9-THC per 12 fluid ounces, or the proportionate equivalent; and 2. Not exceed 12 fluid ounces per container. (c) A consumable hemp product intended for topical application shall not contain more than 1,000 milligrams of total delta-9-THC per package. (d) A consumable hemp product in the form of a tincture shall: 1. Not contain a ratio higher than 2 milligrams of total delta-9-THC per 1 milliliter; and 2. Not exceed 60 milliliters per container.
Ga. Comp. R. & Regs. r. 40-32-5-.01(1)(a) and r. 40-32-5-.06; O.C.G.A. Sec.2-23-3(11) · Standards for Consumable Hemp Products; Serving Sizes and Serving Limits; definition of 'hemp'OFFICIAL
Instrument
Standards for Consumable Hemp Products; Serving Sizes and Serving Limits; definition of 'hemp'
Source
https://rules.sos.ga.gov/gac/40-32-5
Retrieved
2026-07-19
Fingerprint
386b73f6d2ca8168
O.C.G.A. Sec.2-23-3(11): 'Hemp' means the Cannabis sativa L. plant and any part of such plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a total delta-9-THC concentration that does not exceed the legal limit. Ga. Comp. R. & Regs. 40-32-5-.01(1) General Standards. All consumable hemp products in the state of Georgia must conform with the standards established in the Georgia Hemp Farming Act and this Chapter. (a) Prohibited Forms of Consumable Hemp Products. The following products shall not be sold, offered for sale, or otherwise distributed as consumable hemp products in Georgia: 1. The flower or leaves of the Cannabis sativa L. plant, regardless of the total delta-9-THC concentration in such flower or leaves; 2. Products that contain alcohol or constitute an alcoholic beverage under Title 3 of the Official Code of Georgia Annotated; 3. Marijuana products or low THC oil products; 4. Food products, including, but not limited to, dairy, meat, and seafood products; and 5. Any hemp product containing a non-cannabinoid additive that would increase potency, toxicity, or addictive potential, or that would create an unsafe combination with other psychoactive substances including, but not limited to, nicotine. 40-32-5-.06(1) Maximum Serving Sizes and Serving Limits. Consumable hemp products in final packaged form shall not contain an amount of total delta-9-THC in excess of the limits prescribed herein. (a) A consumable hemp product in the form of a gummy shall not contain more than: 1. 10 milligrams of total delta-9-THC per gummy; and 2. 300 milligrams of total delta-9-THC per package. (b) A consumable hemp product in the form of a beverage shall: 1. Not contain more than 10 milligrams of total delta-9-THC per 12 fluid ounces, or the proportionate equivalent; and 2. Not exceed 12 fluid ounces per container. (c) A consumable hemp product intended for topical application shall not contain more than 1,000 milligrams of total delta-9-THC per package. (d) A consumable hemp product in the form of a tincture shall: 1. Not contain a ratio higher than 2 milligrams of total delta-9-THC per 1 milliliter; and 2. Not exceed 60 milliliters per container.
O.C.G.A. § 16-13-25(3) — Schedule I hallucinogenic substances; 4-HO-MET at sub-entry (YYY).MIRROR
Instrument
statute
Source
https://codes.findlaw.com/ga/title-16-crimes-and-offenses/ga-code-sect-16-13-25/
Retrieved
2026-06-19
Fingerprint
975ce376a9303cbe
**§ 16-13-25(3)** "Any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers (whether optical, position, or geometrics), and salts of isomers, unless specifically excepted, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation: … **(YYY) 4-hydroxy-N-methyl-N-ethyltryptamine (4-HO-MET)** …"
— O.C.G.A. § 16-13-25(3)(YYY); text via FindLaw mirror (labeled), "Current as of March 28, 2024": https://codes.findlaw.com/ga/title-16-crimes-and-offenses/ga-code-sect-16-13-25/
Companion prodrug separately listed: "(PPP) 4-acetoxy-N-ethyl-N-methyltryptamine (4-AcO-MET)."
— same section/source
O.C.G.A. 16-13-25 (Schedule I): 2025-2026 amending bills only · O.C.G.A. 16-13-25 (Schedule I): 2025-2026 amending bills onlyOFFICIAL
Instrument
O.C.G.A. 16-13-25 (Schedule I): 2025-2026 amending bills only
Source
https://www.legis.ga.gov/api/legislation/document/20252026/242800
Retrieved
2026-10-08
Fingerprint
9aca7ce7e83f4f83
LC 65 0071 House Bill 1329 By: Representatives Stephens of the 164th and Newton of the 127th A BILL TO BE ENTITLED AN ACT To amend Chapter 13 of Title 16 of the Official Code of Georgia Annotated, relating to controlled substances, so as to provide for certain provisions relating to Schedule I controlled substances; to provide for certain provisions relating to the definition of dangerous drugs; to provide for related matters; to provide for an effective date; to repeal conflicting laws; and for other purposes. BE IT ENACTED BY THE GENERAL ASSEMBLY OF GEORGIA: SECTION 1. Chapter 13 of Title 16 of the Official Code of Georgia Annotated, relating to controlled substances, is amended in Code Section 16-13-25, relating to Schedule I controlled substances, by revising subparagraph (E) of paragraph (16) as follows: "(E) By substitution at the 5-position or 6-position with a nitro, alkyl, halide, cyano, or acetyl group or primary amine;" SECTION 2. Said chapter is further amended in Code Section 16-13-71, relating to dangerous drug, by adding new paragraphs to subsection (b) to read as follows: H. B. 1329 -1- LC 65 0071 "(1.5) Aceclidine;" "(12.7) Acoltremon;" "(17.2) Aficamten;" "(68.45) Atrasentan;" "(69.21) Avutometinib;" "(91.71) Berahyaluronidase alfa-pmph;" "(106.4) Brensocatib;" "(196.3) Clesrovimab-cfor;" "(240.97) Datopotamab deruxtecan-dlnk;" "(243.4) Defactinib;" "(244.7) Delgocitinib;" "(248.5) Depemokimab-ulaa;" "(316.6) Donidalorsen;" "(317.15) Dordaviprone;" "(318.7) Doxecitine;" "(320.5) Doxribtimine;" "(331.0513) Elamipretide;" "(331.0555) Elinzanetant;" "(379.8) Etripamil;" "(386.95) Fitusiran;" "(411.9) Garadacimab-gxii;" "(414.4) Gepotidacin;" "(466.7) Imlunestrant;" "(513.75) Lerodalcibep-liga;" "(523.5) Linvoseltamab-gcpt;" "(619.15) Mirdametinib;" "(640.105) Nerandomilast;" H. B. 1329 -2- LC 65 0071 "(644.605) Nipocalimab-aahu;" "(663.65) Onasemnogene abeparvovec-brve;" "(681.65) Paltusotine;" "(698.5) Penpulimab-kcqx;" "(742.7) Plozasiran;" "(768.6) Prademagene zamikeracel;" "(832.975) Remibrutinib;" "(836.6) Revakinagene taroretcel-lwey;" "(842.3) Rilzabrutinib;" "(852.055) Sebetralstat;" "(855.1) Sepiapterin;" "(855.735) Sevabertinib;" "(855.83) Sibeprenlimab-szsi;" "(927.8) Sunvozertinib;" "(929.7) Suzetrigine;" "(930.978) Taletrectinib;" "(931.565) Telisotuzumab vedotin-tllv;" "(974.65) Treosulfan;" "(1030.9) Vimseltinib;" "(1042.2) Ziftomenib;" "(1042.85) Zoliflodacin;" "(1042.91) Zongertinib;" "(1042.93) Zopapogene imadenovec-drba;" SECTION 3. Said chapter is further amended in subsection (b) of said Code section by repealing and reserving paragraph (324) and by revising paragraphs (60.3), (160.5), and (217.2) as follows: H. B. 1329 -3- LC 65 0071 "(60.3) Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl;" "(160.5) Chikungunya vaccine, Live;" "(217.2) COVID-19 Vaccine, mRNA;" SECTION 4. Said chapter is further amended in subsection (c) of said Code section by revising paragraph (9.33) as follows: "(9.33) Epinephrine , : (A) When when used in a device that delivers a metered spray of 0.125 mg. of epinephrine or less to provide temporary relief for symptoms of mild, intermittent asthma and is a product in finished dosage formulation in its original container that has been approved by and labeled in compliance with the U.S. Food and Drug Administration (FDA); and (B) When distributed by a pharmacist as provided by the State Board of Pharmacy, in a device that delivers a spray of 2 mg. of epinephrine or less to provide emergency treatment of allergic reactions, including anaphylaxis, and is a product in finished dosage formulation in its original container that has been approved by and labeled in compliance with the U.S. Food and Drug Administration (FDA);" SECTION 5. This Act shall become effective upon its approval by the Governor or upon its becoming law without such approval. SECTION 6. All laws and parts of laws in conflict with this Act are repealed. H. B. 1329 -4-
O.C.G.A. 16-13-25(3)(DDDD); Ga. Comp. R. & Regs. r. 480-34-.07(1) · Schedule I -- Hallucinogens (Georgia Board of Pharmacy scheduling rule placing 5-MAPB under O.C.G.A. 16-13-25(3))OFFICIAL
Instrument
Schedule I -- Hallucinogens (Georgia Board of Pharmacy scheduling rule placing 5-MAPB under O.C.G.A. 16-13-25(3))
Source
https://rules.sos.ga.gov/gac/480-34-.07
Retrieved
2026-07-20
Fingerprint
536dedc5bafa1575
(1) This rule was adopted to protect the health, safety, and welfare of the public. This rule places additional newly identified compounds, including any material, compound, mixture, or preparation which contains any quantity of the following substances, their salts, isomers (whether optical, position, or geometrics), and salts of isomers under Schedule I of the Georgia Controlled Substances Act, Section 16-13-25(3) as follows: (BBBB) Methoxyphencyclidine (MeO-PCP); (CCCC) 4-hydroxy-N-methyl-N-isopropyltryptamine (4-OH-MiPT); (DDDD) N,[ALPHA]-dimethyl-5-benzofuranethanamine (5-MAPB); (EEEE) 1-pentyl-N-(phenylmethyl)-1H-indole-3-carboxamide (SDB-006); (FFFF) methyl (S)-2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate (MDMB-CHMICA). (2) This rule is based on the following findings of the Board: (a) that hallucinogens have an extremely high potential for abuse; (b) that scientific evidence and scientific knowledge of the pharmacological effects of these compounds demonstrate that the public is at extreme risk if they are not regulated as controlled substances; (c) that the pattern of abuse of these compounds and the scope and significance of that abuse support regulation; (d) that there exists an imminent peril to the public health and welfare with regard to the abuse of these compounds; (e) that these compounds have the same risk to the public health of citizens of the State of Georgia as other substances already contained in Schedule I under the Controlled Substances Act; and (f) that these compounds have no known precursor already scheduled under the Act.
O.C.G.A. 2-23-3 · DefinitionsMIRROR
Instrument
Definitions
Source
https://law.justia.com/codes/georgia/title-2/chapter-23/section-2-23-3/
Retrieved
2026-07-02
Fingerprint
eed11747be465999
As used in this chapter, the term:

(1) "Attractive to children" means the use of any characters or symbols designed to appeal, or would likely appeal, primarily to individuals under 21 years of age, including but not limited to anthropomorphized animals, creatures, promotional characters, licensed characters, or inanimate objects; depictions of children; or depictions of candy.

(2) "Commercial sale" means the sale of products in the stream of commerce at retail, at wholesale, and online.

(3) "Consumable hemp product" means a hemp product intended to be ingested, absorbed, or inhaled by humans or animals.

(4) "Contaminant" means a foreign substance or compound that may, if ingested, absorbed, or inhaled, have an adverse effect on the health of a human or animal. Such term shall include, without limitation, heavy metals, pesticide residues, residual solvents or processing chemicals, and any other substance or compound that the department determines could, if ingested, absorbed, or inhaled, have an adverse effect on the health of a human or animal.

(5) "Cultivate" means to plant, water, grow, and harvest a plant or crop.

(6) "Delta-9-THC" means delta-9-tetrahydrocannabinol.

(7) "Delta-9-THCA" means delta-9-tetrahydrocannabinolic acid.

(8) Reserved.

(9) "Full panel certificate of analysis" means a report, produced by a laboratory which is unaffiliated with the processor or manufacturer and which has been accredited pursuant to the standards of the International Organization for Standardization for the competence, impartiality, and consistent operation of laboratories, attesting to the composition of a product.

(10) "Handle" means to possess or store hemp plants for any period of time other than during the actual transport of such plants from the premises of a person licensed to cultivate or permitted to process hemp or a college or university authorized to conduct research pursuant to Code Section 2-23-4 to the premises of another licensed or permitted person or to a college or university authorized to conduct research pursuant to Code Section 2-23-4; provided, however, that such term shall not include possessing or storing finished hemp products.

(11) "Hemp" means the Cannabis sativa L. plant and any part of such plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a total delta-9-THC concentration that does not exceed the legal limit.

(12) "Hemp grower licensee" means an individual or business entity possessing a hemp grower license issued by the department under the authority of this chapter to handle and cultivate hemp in the State of Georgia.

(13) "Hemp products" means all products with a total delta-9-THC concentration that does not exceed the legal limit that are derived from, or made by, processing hemp plants or plant parts and that are prepared in a form available for commercial sale.

(14) "Industrial hemp product" means any hemp product that is not a consumable hemp product.

(15) "Key participant" means a sole proprietor, a partner in a partnership, or a person with executive managerial control in a corporation when such sole proprietor, partnership, or corporation is an applicant to be a hemp grower licensee or a permittee. A person with executive managerial control in a corporation includes persons serving as a chief executive officer, chief operating officer, chief financial officer, or any other individual identified in regulations promulgated by the department. Such term shall not include nonexecutive managers, such as farm, field, or shift managers.

(16) "Legal limit" means a total delta-9-THC concentration that is the lesser of:
(A) 0.3 percent; or
(B) The percentage limit set forth in 7 U.S.C. Section 1639o.

(17) "Licensee" means an individual or business entity possessing a license issued by the department under the authority of this chapter.

(18) "Manufacture" means to create, produce, manipulate, combine, or package.

(19) "Manufacturer license" means a license issued by the department under the authority of this chapter to an individual or business entity that manufactures consumable hemp products or industrial hemp products in this state.

(20) "Measurement of uncertainty" means the parameter, associated with the result of a measurement, that characterizes the dispersion of the values that could reasonably be attributed to the particular quantity subject to measurement.

(21) "Permittee" means an individual or business entity possessing a hemp processor permit issued by the department under the authority of this chapter to handle and process hemp in the State of Georgia.

(22)
(A) "Process" or "processing," except as otherwise provided in subparagraph (B) of this paragraph, means converting an agricultural commodity into a legally marketable form.
(B) Such term shall not include:
(i) Merely placing raw or dried material into another container or packaging raw or dried material for resale; or
(ii) Traditional farming practices such as those commonly known as drying, shucking and bucking, storing, trimming, and curing.

(23) "QR code" means a quick response code that is a type of machine-readable, two-dimensional barcode that stores information about a product.

(24) "Registered laboratory" means an individual or business entity that tests or analyzes any plant within the genus Cannabis, including but not limited to hemp, and products made from or derived from such plant, including but not limited to hemp products and consumable hemp products, and that has registered with the department under this chapter.

(25) "Research" or "researching" means experimental field, greenhouse, or laboratory activity for the ultimate purpose of developing new hemp varieties and products, improving existing hemp products, developing new uses for existing hemp products, or developing or improving methods for producing hemp products.

(26) "Retail consumable hemp establishment license" means a license issued by the department under the authority of this chapter to an individual or business entity that prepares or sells prepackaged consumable hemp products to consumers.

(27) "THC" means tetrahydrocannabinol, tetrahydrocannabinolic acid, or a combination of tetrahydrocannabinol and tetrahydrocannabinolic acid.

(28) "Total delta-9-THC concentration" means a concentration of delta-9-THC as determined by Code Section 2-23-3.1.

(29) "Wholesale consumable hemp license" means a license issued by the department under the authority of this chapter to an individual or business entity that sells, in bulk, prepackaged consumable hemp products to retail consumable hemp establishment licensees or to other retail establishments located outside of the State of Georgia that are authorized to sell consumable hemp products to consumers in the jurisdiction where such establishments are located.
O.C.G.A. 2-23-4 · Required licenses; research by colleges and universities; processing of other productsMIRROR
Instrument
Required licenses; research by colleges and universities; processing of other products
Source
https://law.justia.com/codes/georgia/title-2/chapter-23/section-2-23-4/
Retrieved
2026-07-02
Fingerprint
8062e2fde5607ca0
(a) Except as otherwise provided in subsection (b) of this Code section, it shall be unlawful for:

(1) Any person to cultivate hemp in this state unless such person holds a hemp grower license issued by the department pursuant to this chapter or is employed by a hemp grower licensee;

(2) A permittee to accept hemp for processing from any person other than a hemp grower licensee or a college or university authorized to conduct research pursuant to subsection (b) of this Code section, except as otherwise provided in paragraph (4) of this subsection;

(3) A hemp grower licensee to provide or sell hemp to any person other than another hemp grower licensee, a college or university authorized to conduct research pursuant to subsection (b) of this Code section, or a permittee with whom the hemp grower licensee enters into an agreement pursuant to Code Section 2-23-7, unless such person is located in a state with a plan to regulate hemp production that is approved by the secretary of agriculture of the United States, or otherwise in accordance with regulations promulgated by the United States Department of Agriculture, and such person is authorized to grow or process hemp in that state;

(4) A permittee to accept for processing any hemp grown outside of the State of Georgia, unless such hemp is grown in a state with a plan to regulate hemp production that is approved by the secretary of agriculture of the United States or otherwise in accordance with regulations promulgated by the United States Department of Agriculture;

(5) A permittee to process hemp pursuant to a hemp processor permit outside of the State of Georgia, unless such processing occurs in a state with a plan to regulate hemp production that is approved by the secretary of agriculture of the United States or otherwise in accordance with regulations promulgated by the United States Department of Agriculture;

(6) Any hemp grower licensee or permittee to otherwise fail to comply with the requirements of this chapter or any applicable state or federal law or regulation;

(7) Any person to offer for sale at retail the flower or leaves of the Cannabis sativa L. plant, regardless of the total delta-9-THC concentration in such flower or leaves; provided, however, that this paragraph shall not prohibit the sale of any hemp products that include extracts or derivatives of the flower or leaves of such plant; or

(8) Any person to cultivate or handle hemp in any structure that is used for residential purposes.
O.C.G.A. 2-23-4(a)(7); O.C.G.A. 16-12-241 (SB 494, 2024) · O.C.G.A. 2-23-4(a)(7); O.C.G.A. 16-12-241 (SB 494, 2024)OFFICIAL
Instrument
O.C.G.A. 2-23-4(a)(7); O.C.G.A. 16-12-241 (SB 494, 2024)
Source
https://gov.georgia.gov/document/2024-signed-legislation/sb-494/download
Retrieved
2026-10-07
Fingerprint
1384d0c85a73191f
2-23-4(a) [It shall be unlawful for:] ... (7) "Any person to offer for sale at retail the unprocessed flower or leaves of the hemp plant" [...]. 2-23-3(12) "'THC' means tetrahydrocannabinol, tetrahydrocannabinolic acid, or a combination of" "tetrahydrocannabinol and tetrahydrocannabinolic acid." 2-23-4.1(c) [Licensing violators shall] "Be guilty of a misdemeanor for a first offense"; (d) "subject to a civil penalty of not more than $5,000.00 for each violation." 16-12-241: "It shall be unlawful for any person to knowingly sell, furnish, or cause to be furnished" [consumable hemp products to persons under 21]. SB 494 Sec. 20: "The remaining sections of this Act shall become effective on October 1, 2024." [Bracketed spans summarized.]
O.C.G.A. Sec. 16-13-120/121/122 (Kratom Consumer Protection Act, Art. 6) · GA KCPA - 0.5 mg/g + 1 mg/serving 7-OH cap + 150 mg/serving mitragynine, synthetic ban, age 21, no vapeOFFICIAL
Instrument
GA KCPA - 0.5 mg/g + 1 mg/serving 7-OH cap + 150 mg/serving mitragynine, synthetic ban, age 21, no vape
Source
https://www.lexisnexis.com/hottopics/gacode/
Retrieved
2026-07-07
Fingerprint
a6b64f295756c573
16-13-120 Definitions. (2) "Kratom" means the tropical evergreen known as Mitragyna speciosa ... which ... contains the alkaloid mitragynine or metabolite 7-hydroxymitragynine. (4) "Kratom product" means a product containing any part of the leaf of the plant mitragyna ... 16-13-121 (a)(1) No person shall knowingly sell or transfer possession of any kratom ... to another person under 21 years of age ... (b) No person shall ingest kratom in a manner that employs a heating element ... [vape ban] ... (d) [behind-counter/secured display]. 16-13-122 (a) All kratom products ... shall not be modified, chemically or otherwise, ... in any way that increases the levels of mitragynine or 7-hydroxymitragynine beyond those in subsection (b). (b) No kratom product ... shall have a concentration ratio that is: (1) Greater than 150 mg of mitragynine per serving; (2) Greater than 0.5 mg 7-hydroxymitragynine per gram; or (3) Greater than 1 mg 7-hydroxymitragynine per serving. (c) A processor or retailer shall not prepare, distribute, sell, or expose for sale: (1) adulterated; (2) not GRAS food substance; (3) A kratom product containing any synthetic alkaloids or metabolite including synthetic mitragynine, synthetic 7-hydroxymitragynine, or any other synthetically derived compounds of the kratom plant; or (4) [vape form]. (e) [labeling incl. mitragynine + 7-OH amounts]. (f)-(g) penalties (processor felony tier up to 15 yrs; retailer tiered).

Neighboring states

Cite this page

Compound Analytics. "Georgia Compound Laws (2026): Kratom, 7-OH, Hemp THC, Delta-8 and More." Compound Laws, https://compoundlaws.com/states/georgia/. Accessed October 25, 2026.

Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.

About · Methodology · Glossary · Changes · Data & API · llms.txt · Sitemap